# SERPINB8

## Overview
SERPINB8 is a gene that encodes the protein serpin family B member 8, a member of the serpin superfamily of serine protease inhibitors. This protein is primarily involved in the regulation of protease activity within the cytoplasm of human cells, playing a critical role in maintaining cellular homeostasis and protecting tissues from protease-mediated damage. SERPINB8 is particularly noted for its specific inhibition of the enzyme furin, a subtilase-type protease, which is essential for processes such as inflammation and tissue remodeling. The protein's structure, characterized by a conserved serpin fold and a reactive center loop, is crucial for its inhibitory function and selectivity. SERPINB8 is expressed across various tissues, including the liver, heart, and skeletal muscle, indicating its widespread physiological importance. Additionally, its potential therapeutic applications in modulating protease activity in autoimmune diseases and other pathological conditions are of significant interest (Badola2006Correlation; Izaguirre2013Identification; Kryvalap2022The).

## Structure
SERPINB8 is a member of the serpin superfamily, characterized by a conserved tertiary structure known as the serpin fold, which includes three β-sheets and several α-helices. This structure is crucial for its function as a serine protease inhibitor. The protein can undergo post-translational modifications, such as phosphorylation, which may influence its activity and stability (Izaguirre2013Identification).

The primary structure of SERPINB8 includes a reactive center loop (RCL) that plays a significant role in its specificity and selectivity for inhibiting the proprotein convertase furin. The RCL contains critical Arg-X-X-Arg sequences that are essential for its inhibitory function (Izaguirre2013Identification). Mutations in these sequences can alter the protein's reactivity with furin, highlighting the importance of the RCL in its inhibitory mechanism (Izaguirre2013Identification).

SERPINB8 can exist in multiple isoforms due to alternative splicing, which may result in variations in its structure and function (Izaguirre2013Identification). The protein is typically expressed as a monomer, but it can form disulfide-linked multimers due to its cysteine residues. To study its monomeric form, cysteines were mutated to serines or alanines, stabilizing the protein for experimental analysis (Izaguirre2013Identification).

## Function
SERPINB8, also known as CAP2 or PI8, is a member of the serpin family of protease inhibitors, primarily functioning within the cytoplasm of healthy human cells. It plays a crucial role in regulating protease activity, which is essential for maintaining cellular homeostasis and protecting cells from protease-mediated damage. SERPINB8 inhibits several proteases, including furin, trypsin, factor Xa, thrombin, chymotrypsin, and subtilisin A, helping to maintain a balance between proteases and antiproteases (Kryvalap2022The).

In particular, SERPINB8 is a specific and selective inhibitor of the enzyme furin, reacting at a physiologically relevant rate. This inhibition is crucial for regulating processes such as inflammation and tissue remodeling, as well as preventing excessive protease activity that could lead to tissue damage or disease (Badola2006Correlation; Izaguirre2019Specific). The protein is ubiquitously expressed across various tissues, including the liver, skeletal muscle, artery, heart, and coronary smooth muscle cells, indicating its widespread role in maintaining normal physiological functions (Badola2006Correlation). Additionally, SERPINB8 may have therapeutic potential in modulating protease activity in autoimmune diseases (Kryvalap2022The).

## Clinical Significance
Mutations and alterations in the expression of the SERPINB8 gene have been associated with various skin disorders and potentially other conditions. One notable mutation, SERPINB8_K158N, has been identified with a low SIFT score of 0.02, indicating a potentially deleterious effect, although the primary focus of the study was on prostate cancer risk associated with other SERPINB genes (Shioji2005Nucleotide). While the specific clinical implications of SERPINB8 mutations are not extensively detailed in the provided context, the gene's role as a serine protease inhibitor suggests that changes in its function could contribute to inflammatory conditions and certain cancers. The context does not provide direct evidence linking SERPINB8 mutations to specific diseases, but its involvement in protease inhibition and cellular protection implies that disruptions could lead to pathological states. The study by Izaguirre et al. focuses on the biochemical characterization of SERPINB8 and its interaction with furin, providing insights into its specificity and selectivity as a furin inhibitor, which could have implications for designing therapeutic inhibitors (Izaguirre2013Identification). However, the clinical significance of these interactions remains to be fully elucidated.

## Interactions
SERPINB8 is known to interact with the subtilase-type protease furin, exhibiting a strong correlation in expression across various human tissues, including the liver, skeletal muscle, artery, heart, and coronary smooth muscle cells (Badola2006Correlation). This interaction is characterized by SERPINB8's ability to inhibit furin in vitro with a K_i of 54 pM, suggesting a regulatory role in vivo (Badola2006Correlation). The interaction between SERPINB8 and furin is highly selective, with SERPINB8 reacting 20 times faster with furin than with other proprotein convertases such as PC4, PC5, PACE4, and PC7 (Izaguirre2019Specific). This selectivity is attributed to the specific structural conformation of SERPINB8's reactive center loop and exosite elements, which enhance its reactivity with furin (Izaguirre2019Specific).

In addition to its interaction with furin, SERPINB8 has been implicated in potential antiviral roles, as suggested by in-silico docking studies that predict its interactions with a limited number of proteases involved in viral life cycles (Rodriguez2022Insilicodocking). These interactions highlight SERPINB8's potential involvement in regulating protease activity in both physiological and pathological contexts.


## References


1. (Rodriguez2022Insilicodocking) In-silicodocking platform with serine protease inhibitor (SERPIN) structures identifies host cysteine protease targets with significance for SARS-CoV-2. This article has 1 citations.

[2. (Shioji2005Nucleotide) Go Shioji, Yoichi Ezura, Toshiaki Nakajima, Kenji Ohgaki, Hiromichi Fujiwara, Yoshinobu Kubota, Tomohiko Ichikawa, Katsuki Inoue, Taro Shuin, Tomonori Habuchi, Osamu Ogawa, Taiji Nishimura, and Mitsuru Emi. Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor b10 associated with prostate cancer. Journal of Human Genetics, 50(10):507–515, September 2005. URL: http://dx.doi.org/10.1007/s10038-005-0285-1, doi:10.1007/s10038-005-0285-1. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10038-005-0285-1)

[3. (Izaguirre2013Identification) Gonzalo Izaguirre, Lixin Qi, Mary Lima, and Steven T. Olson. Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of α1pdx (α1-protease inhibitor portland)-serpin b8 and furin active-site loop chimeras. Journal of Biological Chemistry, 288(30):21802–21814, July 2013. URL: http://dx.doi.org/10.1074/jbc.M113.462804, doi:10.1074/jbc.m113.462804. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M113.462804)

[4. (Izaguirre2019Specific) Gonzalo Izaguirre, Marcelino Arciniega, and Andrea G. Quezada. Specific and selective inhibitors of proprotein convertases engineered by transferring serpin b8 reactive-site and exosite determinants of reactivity to the serpin α1pdx. Biochemistry, 58(12):1679–1688, March 2019. URL: http://dx.doi.org/10.1021/acs.biochem.8b01295, doi:10.1021/acs.biochem.8b01295. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.8b01295)

[5. (Badola2006Correlation) Sunita Badola, Heidi Spurling, Keith Robison, Eric R. Fedyk, Gary A. Silverman, Jochen Strayle, Rosana Kapeller, and Christopher A. Tsu. Correlation of serpin–protease expression by comparative analysis of real-time pcr profiling data. Genomics, 88(2):173–184, August 2006. URL: http://dx.doi.org/10.1016/j.ygeno.2006.03.017, doi:10.1016/j.ygeno.2006.03.017. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2006.03.017)

[6. (Kryvalap2022The) Yury Kryvalap and Jan Czyzyk. The role of proteases and serpin protease inhibitors in β-cell biology and diabetes. Biomolecules, 12(1):67, January 2022. URL: http://dx.doi.org/10.3390/biom12010067, doi:10.3390/biom12010067. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom12010067)